Related Experiment Video
Updated: Nov 16, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis
Radha Mukherjee1, Kiran G Vanaja2, Jacob A Boyer1
1Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Abstract:
The PI3K pathway regulates cell metabolism, proliferation, and migration, and its dysregulation is common in cancer. We now show that both physiologic and oncogenic activation of PI3K signaling increase the expression of its negative regulator PTEN. This limits the duration of the signal and output of the pathway. Physiologic and pharmacologic inhibition of the pathway reduces PTEN and contributes to the rebound in pathway activity in tumors treated with PI3K inhibitors and limits their efficacy. Regulation of PTEN is due to mTOR/4E-BP1-dependent control of its translation and is lost when 4E-BP1 is deleted. Translational regulation of PTEN is therefore a major homeostatic regulator of physiologic PI3K signaling and plays a role in reducing the pathway activation by oncogenic PIK3CA mutants and the antitumor activity of PI3K pathway inhibitors. However, pathway output is hyperactivated in tumor cells with coexistent PI3K mutation and loss of PTEN function.
Insights
The PI3K pathway
Area of Science:
- Cellular signaling and cancer biology.
- Molecular mechanisms of cancer progression and treatment resistance.
Background:
- The phosphoinositide 3-kinase (PI3K) pathway is crucial for cell functions, and its aberrant activation is prevalent in various cancers.
- PTEN acts as a key negative regulator of the PI3K pathway, maintaining cellular homeostasis.
Purpose of the Study:
- To investigate the role of PTEN regulation in controlling PI3K pathway signaling duration and output.
- To elucidate the impact of PTEN regulation on the efficacy of PI3K pathway inhibitors in cancer treatment.
Main Methods:
- Analysis of PTEN expression in response to PI3K pathway activation (physiologic and oncogenic).
- Investigation of the translational control of PTEN by mTOR/4E-BP1.
- Assessment of PI3K pathway activity and inhibitor efficacy in models with altered PTEN and 4E-BP1 levels.
Main Results:
- Both physiologic and oncogenic PI3K activation upregulate PTEN expression, limiting pathway signaling duration.
- Inhibition of the PI3K pathway leads to decreased PTEN levels, contributing to pathway rebound and reduced efficacy of PI3K inhibitors.
- mTOR/4E-BP1-dependent translational control of PTEN is identified as a major homeostatic mechanism, which is lost upon 4E-BP1 deletion.
- Tumor cells with concurrent PI3K mutation and PTEN loss exhibit hyperactivated pathway output.
Conclusions:
- Translational regulation of PTEN is a critical homeostatic mechanism for PI3K signaling.
- This PTEN regulation influences the response to oncogenic PI3K activation and the effectiveness of PI3K inhibitors.
- Understanding PTEN's role in PI3K pathway regulation is vital for developing more effective cancer therapies.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
Negative Regulator Molecules

